Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, December 4, 2024.
CytomX Therapeutics, Inc. (NASDAQ:CTMX)
Long-Term Uptrend (+90) - CTMX is in a strong uptrend that is likely to continue. While CTMX is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid CTMX?
MarketClub looks at technical strength and momentum to determine if the timing is right for CTMX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CTMX
The long-term trend has been UP since Dec 3rd, 2024 at 1.33
The intermediate-term trend has been UP since Dec 2nd, 2024 at 1.10
The short-term trend has been UP since Nov 25th, 2024 at 0.92
Smart Scan Analysis for CTMX
Based on our trend formula, CTMX is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.22 | 1.42 | 1.21 | 1.30 | +0.07 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.23 | 3815289 | 2024-12-04 15:59:47 |
| Year High | 35 | Year High Date | 2018-03-08 |
| Year Low | 12.51 | Year Low Date | 2018-11-20 |
| 52wk High | 5.85 | 52wk High Date | 2024-05-01 |
| 52wk Low | 0.833 | 52wk Low Date | 2024-11-19 |
| Average Volume | 1,662,174 | Shares Outstanding | 78,259 |
| Market Cap | 450M | Assets | 159,219,000M |
| Liabilities | 190,446,000M | P/E Ratio | 8.7857 |
| Volatility | 104.36 |